Form 8-K - Current report:
SEC Accession No. 0000950142-23-001077
Filing Date
2023-04-13
Accepted
2023-04-13 16:26:23
Documents
14
Period of Report
2023-04-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eh230348996_8k.htm   iXBRL 8-K 34969
2 EXHIBIT 99.1 eh230348996_ex9901.htm EX-99.1 23623
3 GRAPHIC logo.jpg GRAPHIC 2655
  Complete submission text file 0000950142-23-001077.txt   247899

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE exel-20230412.xsd EX-101.SCH 3227
5 XBRL LABEL FILE exel-20230412_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE exel-20230412_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT eh230348996_8k_htm.xml XML 3486
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30235 | Film No.: 23818641
SIC: 2836 Biological Products, (No Diagnostic Substances)